Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients
NCT04346446
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
29
Enrollment
OTHER
Sponsor class
Conditions
COVID
Interventions
DRUG:
Convalescent Plasma Transfusion
OTHER:
Supportive Care
DRUG:
Random Donor Plasma
Sponsor
Institute of Liver and Biliary Sciences, India